Bilaal.Raja
Company record

SPRB  SPRUCE BIOSCIENCES, INC.

Trailing twelve months to 2025-12-31, as filed 2026-03-09 and not restated since.
Healthcare

Scale

Market cap
$178m
Revenue TTM
$0m
Net income TTM
$-39m
Free cash flow
Composite score
Sector rank
#2916

Valuation

P / E
EV / EBITDA
EV / sales
FCF yield
Yield vs 10-yr
-26.60pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
EBITDA margin
ROE
-91.7%
ROIC
Revenue growth
-100.0%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We have incurred and will continue to incur significant increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.SPRUCE BIOSCIENCES, INC., 10-Q, period ended 2026-06-30, filed 2026-08-12

Read the full passage →